Stay updated with breaking news from Stephan stenglein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Atriva Therapeutics GmbH / Key word(s): Conference Atriva Therapeutics to take part in upcoming scientific and industry conferences in early 2022 20.12.2021 / 10:00 The ....
DGAP-News: Atriva Therapeutics GmbH: Atriva Therapeutics Announces Changes to Management Atriva Therapeutics Announces Changes to Management 13.04.2021 / 09:30 Atriva Therapeutics Announces Changes to Management - Olaf Althaus appointed Chief Financial Officer - Stephan Stenglein, M.D., recently joined as Chief Medical Officer - Proven track record and 20+ years of experience in their respective fields of expertise Tübingen (Germany), April 13, 2021 - Atriva Therapeutics GmbH, a biopharmaceutical company that is pioneering the development of host-targeting antiviral therapies, today announced two changes to its management team. Olaf Althaus was appointed Chief Financial Officer, effective May 2020, while Stephan Stenglein, M.D., was named Chief Medical Officer, effective February 2021. ....